Cargando…

Clinical presentation, management, screening and surveillance for colorectal cancer during the COVID-19 pandemic

Management of colorectal cancer (CRC) was severely affected by the changes implemented during the pandemic, and this resulted in delayed elective presentation, increased emergency presentation, reduced screening and delayed definitive therapy. This review was conducted to analyze the impact of the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Akbulut, Sami, Hargura, Abdirahman Sakulen, Garzali, Ibrahim Umar, Aloun, Ali, Colak, Cemil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477669/
https://www.ncbi.nlm.nih.gov/pubmed/36159422
http://dx.doi.org/10.12998/wjcc.v10.i26.9228
_version_ 1784790413697089536
author Akbulut, Sami
Hargura, Abdirahman Sakulen
Garzali, Ibrahim Umar
Aloun, Ali
Colak, Cemil
author_facet Akbulut, Sami
Hargura, Abdirahman Sakulen
Garzali, Ibrahim Umar
Aloun, Ali
Colak, Cemil
author_sort Akbulut, Sami
collection PubMed
description Management of colorectal cancer (CRC) was severely affected by the changes implemented during the pandemic, and this resulted in delayed elective presentation, increased emergency presentation, reduced screening and delayed definitive therapy. This review was conducted to analyze the impact of the coronavirus disease 2019 (COVID-19) pandemic on management of CRC and to identify the changes made in order to adapt to the pandemic. We performed a literature search in PubMed, Medline, Index Medicus, EMBASE, SCOPUS, Reference Citation Analysis (https://www.referencecitationanalysis.com/) and Google Scholar using the following keywords in various combinations: Colorectal cancer, elective surgery, emergency surgery, stage upgrading, screening, surveillance and the COVID-19 pandemic. Only studies published in English were included. To curtail the spread of COVID-19 infection, there were modifications made in the management of CRC. Screening was limited to high risk individuals, and the screening tests of choice during the pandemic were fecal occult blood test, fecal immunochemical test and stool DNA testing. The use of capsule colonoscopy and open access colonoscopy was also encouraged. Blood-based tests like serum methylated septin 9 were also encouraged for screening of CRC during the pandemic. The presentation of CRC was also affected by the pandemic with more patients presenting with emergencies like obstruction and perforation. Stage migration was also observed during the pandemic with more patients presenting with more advanced tumors. The operative therapy of CRC was altered by the pandemic as more emergencies surgeries were done, which may require exteriorization by stoma. This was to reduce the morbidity associated with anastomosis and encourage early discharge from the hospital. There was also an initial reduction in laparoscopic surgical procedures due to the fear of aerosols and COVID-19 infection. As we gradually come out of the pandemic, we should remember the lessons learned and continue to apply them even after the pandemic passes.
format Online
Article
Text
id pubmed-9477669
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Baishideng Publishing Group Inc
record_format MEDLINE/PubMed
spelling pubmed-94776692022-09-23 Clinical presentation, management, screening and surveillance for colorectal cancer during the COVID-19 pandemic Akbulut, Sami Hargura, Abdirahman Sakulen Garzali, Ibrahim Umar Aloun, Ali Colak, Cemil World J Clin Cases Minireviews Management of colorectal cancer (CRC) was severely affected by the changes implemented during the pandemic, and this resulted in delayed elective presentation, increased emergency presentation, reduced screening and delayed definitive therapy. This review was conducted to analyze the impact of the coronavirus disease 2019 (COVID-19) pandemic on management of CRC and to identify the changes made in order to adapt to the pandemic. We performed a literature search in PubMed, Medline, Index Medicus, EMBASE, SCOPUS, Reference Citation Analysis (https://www.referencecitationanalysis.com/) and Google Scholar using the following keywords in various combinations: Colorectal cancer, elective surgery, emergency surgery, stage upgrading, screening, surveillance and the COVID-19 pandemic. Only studies published in English were included. To curtail the spread of COVID-19 infection, there were modifications made in the management of CRC. Screening was limited to high risk individuals, and the screening tests of choice during the pandemic were fecal occult blood test, fecal immunochemical test and stool DNA testing. The use of capsule colonoscopy and open access colonoscopy was also encouraged. Blood-based tests like serum methylated septin 9 were also encouraged for screening of CRC during the pandemic. The presentation of CRC was also affected by the pandemic with more patients presenting with emergencies like obstruction and perforation. Stage migration was also observed during the pandemic with more patients presenting with more advanced tumors. The operative therapy of CRC was altered by the pandemic as more emergencies surgeries were done, which may require exteriorization by stoma. This was to reduce the morbidity associated with anastomosis and encourage early discharge from the hospital. There was also an initial reduction in laparoscopic surgical procedures due to the fear of aerosols and COVID-19 infection. As we gradually come out of the pandemic, we should remember the lessons learned and continue to apply them even after the pandemic passes. Baishideng Publishing Group Inc 2022-09-16 2022-09-16 /pmc/articles/PMC9477669/ /pubmed/36159422 http://dx.doi.org/10.12998/wjcc.v10.i26.9228 Text en ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. https://creativecommons.org/licenses/by-nc/4.0/This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
spellingShingle Minireviews
Akbulut, Sami
Hargura, Abdirahman Sakulen
Garzali, Ibrahim Umar
Aloun, Ali
Colak, Cemil
Clinical presentation, management, screening and surveillance for colorectal cancer during the COVID-19 pandemic
title Clinical presentation, management, screening and surveillance for colorectal cancer during the COVID-19 pandemic
title_full Clinical presentation, management, screening and surveillance for colorectal cancer during the COVID-19 pandemic
title_fullStr Clinical presentation, management, screening and surveillance for colorectal cancer during the COVID-19 pandemic
title_full_unstemmed Clinical presentation, management, screening and surveillance for colorectal cancer during the COVID-19 pandemic
title_short Clinical presentation, management, screening and surveillance for colorectal cancer during the COVID-19 pandemic
title_sort clinical presentation, management, screening and surveillance for colorectal cancer during the covid-19 pandemic
topic Minireviews
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9477669/
https://www.ncbi.nlm.nih.gov/pubmed/36159422
http://dx.doi.org/10.12998/wjcc.v10.i26.9228
work_keys_str_mv AT akbulutsami clinicalpresentationmanagementscreeningandsurveillanceforcolorectalcancerduringthecovid19pandemic
AT harguraabdirahmansakulen clinicalpresentationmanagementscreeningandsurveillanceforcolorectalcancerduringthecovid19pandemic
AT garzaliibrahimumar clinicalpresentationmanagementscreeningandsurveillanceforcolorectalcancerduringthecovid19pandemic
AT alounali clinicalpresentationmanagementscreeningandsurveillanceforcolorectalcancerduringthecovid19pandemic
AT colakcemil clinicalpresentationmanagementscreeningandsurveillanceforcolorectalcancerduringthecovid19pandemic